Michele Mercuri

Daiichi Sankyo Pharma Development

Affiliated withDaiichi Sankyo Pharma Development

Research Area

Biography

Michele Mercuri has not added Biography.
If you are Michele Mercuri and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2015

Other Publications

Article	Year
Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease. Circulation\| PubMed ID: 12379574	2002
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation\| PubMed ID: 12390953	2002
Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients. The American journal of cardiology\| PubMed ID: 12398959	2002
Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation\| PubMed ID: 12460866	2002
Radical-trapping activity, blood pressure, and carotid enlargement in women. Hypertension\| PubMed ID: 12574097	2003
Carotid arterial structure in patients with documented coronary artery disease and disease-free control subjects. Circulation\| PubMed ID: 12615793	2003
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups. Clinical cardiology\| PubMed ID: 14640465	2003
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS... The American journal of cardiology\| PubMed ID: 14715336	2004
Coronary artery calcium outperforms carotid artery intima-media thickness as a noninvasive index of prevalent coronary artery stenosis. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 15947237	2005
Blood leukocyte count is a risk factor for intima-media thickening and subclinical carotid atherosclerosis in middle-aged men. Atherosclerosis\| PubMed ID: 16378612	2006
The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus. The Journal of rheumatology\| PubMed ID: 18050371	2007
The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes. Clinical biochemistry\| PubMed ID: 18280811	2008
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next G... American heart journal\| PubMed ID: 20934556	2010
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. The New England journal of medicine\| PubMed ID: 23991658	2013
Edoxaban versus warfarin in patients with atrial fibrillation. The New England journal of medicine\| PubMed ID: 24251359	2013
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. European heart journal\| PubMed ID: 24302269	2014
Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thr... Stroke; a journal of cerebral circulation\| PubMed ID: 24947287	2014
Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial. Journal of the American College of Cardiology\| PubMed ID: 25104527	2014
Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation† European heart journal\| PubMed ID: 25687352	2015
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet\| PubMed ID: 25769357	2015
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet\| PubMed ID: 25769361	2015
A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin a... Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists\| PubMed ID: 25809373	2015
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atria... American heart journal\| PubMed ID: 25965706	2015